Increased Matrix Metalloproteinase-2 and Matrix Metalloproteinase-3 Concentrations in Corneal Epithelium of Patients with Recurrent Corneal Erosions

Overview

Journal J Ophthalmol

Publisher Wiley

Specialty Ophthalmology

Date 2022 Oct 6

PMID 36199293

Authors

Katarzyna Jadczyk-Sorek

Wojciech Garczorz

Beata Bubala-Stachowicz

Tomasz Francuz

Ewa Mrukwa-Kominek

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the role of selected matrix metalloproteinases in defective corneal re-epithelization in patients with recurrent corneal erosions.

Subjects: The study group (group 1) included patients with recurrent corneal erosions qualified for phototherapeutic keratectomy. The group 1 was divided into two subgroups regarding the etiology of recurrent corneal erosions: group 1A, Cogan's basement membrane dystrophy, and group 1B, trauma. The control group (group 2) included patients with healthy eyes qualified for Epi-Bowman Keratectomy.

Methods: The analyzed material was the corneal epithelium collected during phototherapeutic keratectomy or Epi-Bowman Keratectomy in the study or control group, respectively. Matrix metalloproteinases concentration was determined by an immunohistochemical method using Human Magnetic Luminex® Assay.

Results: The study revealed a statistically significantly higher concentration of matrix metalloproteinase-2 in group 1 compared to the control and a statistically significantly higher concentration of matrix metalloproteinase-3 in group 1 compared to the control.

Conclusions: The results obtained in the study can prove that matrix metalloproteinase-2 and matrix metalloproteinase-3 having the ability to dissolve anchoring fibers and the corneal epithelial basement membrane could be responsible for epithelial instability and their accumulation in the corneal epithelium may induce recurrence of erosion.

Citing Articles

Matrix Metalloproteinases and the Pathogenesis of Recurrent Corneal Erosions and Epithelial Basement Membrane Dystrophy.

Jadczyk-Sorek K, Garczorz W, Bubala-Stachowicz B, Francuz T, Mrukwa-Kominek E Biology (Basel). 2023; 12(9).

PMID: 37759662 PMC: 10525265. DOI: 10.3390/biology12091263.

Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy.

Ruiz-Lozano R, Azar N, Mousa H, Quiroga-Garza M, Komai S, Wheelock-Gutierrez L Front Toxicol. 2023; 5:1067942.

PMID: 37547228 PMC: 10403269. DOI: 10.3389/ftox.2023.1067942.

References

Matsubara M, Girard M, Kublin C, Cintron C, Fini M . Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol. 1991; 147(2):425-39. DOI: 10.1016/0012-1606(91)90300-r. View

Nagase H, Visse R, Murphy G . Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-73. DOI: 10.1016/j.cardiores.2005.12.002. View

Klein T, Bischoff R . Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2010; 41(2):271-90. PMC: 3102199. DOI: 10.1007/s00726-010-0689-x. View

Wood T . Recurrent erosion. Trans Am Ophthalmol Soc. 1984; 82:850-98. PMC: 1298681. View

Sivak J, Fini M . MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002; 21(1):1-14. DOI: 10.1016/s1350-9462(01)00015-5. View

Fini M, Parks W, Rinehart W, Girard M, Matsubara M, Cook J . Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996; 149(4):1287-302. PMC: 1865201. View

Fini M, Girard M . Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 1990; 31(9):1779-88. View

Nassaralla B, Nassaralla Junior J . Ten-year results of phototherapeutic keratectomy on recurrent corneal erosions. Arq Bras Oftalmol. 2012; 75(1):33-7. View

Li D, Shang T, Kim H, Solomon A, Lokeshwar B, Pflugfelder S . Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003; 44(7):2928-36. DOI: 10.1167/iovs.02-0874. View

10.

Ziakas N, Boboridis K, Terzidou C, Naoumidi T, Mikropoulos D, Georgiadou E . Long-term follow up of autologous serum treatment for recurrent corneal erosions. Clin Exp Ophthalmol. 2010; 38(7):683-7. DOI: 10.1111/j.1442-9071.2010.02304.x. View

11.

Brew K, Nagase H . The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010; 1803(1):55-71. PMC: 2853873. DOI: 10.1016/j.bbamcr.2010.01.003. View

12.

Chell P, Kervick G, McDonnell P, Jones H . Oral tetracycline in the treatment of recurrent corneal erosions. Eye (Lond). 1994; 8 ( Pt 4):384-8. DOI: 10.1038/eye.1994.91. View

13.

Sridhar M, Rapuano C, Cosar C, Cohen E, Laibson P . Phototherapeutic keratectomy versus diamond burr polishing of Bowman's membrane in the treatment of recurrent corneal erosions associated with anterior basement membrane dystrophy. Ophthalmology. 2002; 109(4):674-9. DOI: 10.1016/s0161-6420(01)01027-2. View

14.

Meduri A, Scorolli L, Scalinci S, Grenga P, Lupo S, Rechichi M . Effect of the combination of basic fibroblast growth factor and cysteine on corneal epithelial healing after photorefractive keratectomy in patients affected by myopia. Indian J Ophthalmol. 2013; 62(4):424-8. PMC: 4064216. DOI: 10.4103/0301-4738.119420. View

15.

Chan E, Jhanji V, Constantinou M, Amiel H, Snibson G, Vajpayee R . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. Br J Ophthalmol. 2013; 98(2):166-71. DOI: 10.1136/bjophthalmol-2013-303276. View

16.

Sakimoto T, Sawa M . Metalloproteinases in corneal diseases: degradation and processing. Cornea. 2012; 31 Suppl 1:S50-6. DOI: 10.1097/ICO.0b013e318269ccd0. View

17.

Kim M, Song S, Kim J, Woo H . Multifocal phototherapeutic keratectomy for the treatment of persistent epithelial defect. J Cataract Refract Surg. 2001; 26(12):1753-7. DOI: 10.1016/s0886-3350(00)00640-4. View

18.

Tripathi R, Bron A . Ultrastructural study of non-traumatic recurrent corneal erosion. Br J Ophthalmol. 1972; 56(2):73-85. PMC: 1208691. DOI: 10.1136/bjo.56.2.73. View

19.

Lu Y, Fukuda K, Liu Y, Kumagai N, Nishida T . Dexamethasone inhibition of IL-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture. Invest Ophthalmol Vis Sci. 2004; 45(9):2998-3004. DOI: 10.1167/iovs.04-0051. View

20.

Mohan R, Chintala S, Jung J, Villar W, McCabe F, Russo L . Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem. 2001; 277(3):2065-72. DOI: 10.1074/jbc.M107611200. View